Animas Insulin Pump Attorney Animas Insulin Pump Recall
 
On November 21, 2008 Animas Corporation and FDA informed consumers and healthcare professionals of a nationwide recall of battery caps used with the OneTouch Ping System, Animas 2020 Insulin Pump, Animas IR1200 Insulin Pump, and Animas IR1250 Insulin Pump. If you or a loved one have suffered injury or loss due to a defective insulin pump you may be entitled to compensation. Contact the Insulin Pump Attorneys of Ennis & Ennis, P.A. today for a free case evaluation.
Animas Insulin Pump - Battery Cap Recall - News
Free Case Evaluation

Animas battery caps on insulin pumps recalled

-EndocrineToday

11/28/2008- The FDA has announced a Class 1 nationwide recall of Animas Corporation battery caps used with the Animas 2020, IR1200 and IR1250 insulin pumps and OneTouch Ping System.

The recall notice describes intermittent loss of contact between the battery cap and battery compartment in the insulin pump that may result in the device resetting, potentially leading to hyperglycemia or hypoglycemia.

Animas Corporation and the FDA advised health care professionals to inform patients to replace the battery cap on their insulin pump.

The battery caps and insulin systems of concern include:

- All Animas battery caps manufactured from June 1, 2008 through July 31, 2008 and distributed from June 16, 2008 to Aug. 1, 2008.

- All OneTouch Ping Glucose Management Systems shipped before Aug. 1, 2008.

- All Animas 2020 Insulin Pumps shipped from June 16, 2008 to July, 19, 2008.

- All Animas IR1200 and IR1250 insulin pumps shipped from June 16, 2008 to Aug. 1, 2008.

Class 1 recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious injury or death, according to the FDA.

Animas Corporation sent warning letters to patients and distributors from Aug. 18, 2008 to Sept. 1, 2008, warning of the defective battery caps. The manufacturer provided replacement battery caps for patients and instructions for retrieval, replacement and disposal of defective battery caps for distributors. Animas Corporation will continue its efforts to contact all patients regarding the recall.

Meantime, health care professionals and consumers may report adverse events with use of these products to the FDA’s MedWatch Adverse Event Reporting program.

 

Click Here To Visit Our Blog Page
Required fields in yellow
 
Name:
Email:
 
Telephone: (123-123-1234)
 
Mailing Address:
 
City:
 
State:
 
Zip Code:
On whose behalf are you inquiring?
Is the person deceased?
Yes No
If the person is deceased please list the cause of death as listed on the death certificate:
 
Please list the dates that the insulin pump was used:
To
 
Please list any side effects of the insulin pump that you have been diagnosed with:
 
When did you seek medical attention for the side effects you listed above?
 
What state where you living in when you used the insulin pump?
 
Please list the date you realized that the insulin pump was the cause of your problems:
 
How did you find out that the insulin pump was the cause of your problems?
 
Please list any additional information you feel may be relevant to your potential case:
 
How did you hear about us?
 
 
 

 

 
Nationwide Free Case Evaluations: 1-800-856-6405